Irvine, CA — December 2, 2025: PFD Capital Partners congratulates Christopher Woodson, MD, on completing his 1,000th Mako Robotic Joint Replacement, marking a major milestone in his distinguished orthopedic career. As PFD’s Principal Investigator for Clinical Operations, Dr. Woodson has been key in developing the patented iKnee™ Resurfacing System, a less invasive, cartilage-preserving alternative to total knee arthroplasty (TKA). For more information, email us at info@pfdcap.com.